- NSE
Anthem Biosciences Ltd
Healthcare ANTHEM
606.75INR
-0.65
(
-0.11%)
Last update at
Day Range
52 Week Range
Fundamentals
- Previous Close 607.40
- Market Cap 416096.85M
- Volume131,803
- P/E Ratio 91.92
- EBITDA 6758.82M
- Revenue TTM 18503.90M
- Revenue Per Share TTM 33.10
- Gross Profit TTM 10689.22M
- Diluted EPS TTM 8.06
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Financials
Income Statement
Balance Sheet
Change in Cash
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Income before tax | 6568.68M | 4773.18M | 4972.97M | 5461.41M |
| Net income | 4512.59M | 3673.10M | 3851.85M | 4055.39M |
| Total Revenue | 18445.53M | 14193.70M | 10569.24M | 12312.56M |
| Gross Profit | 11006.41M | 8198.19M | 7176.47M | 8223.32M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Total assets | 28075.83M | 23981.14M | 20144.58M | 16188.67M |
| Intangible assets | 38.71M | 62.43M | 90.89M | 68.99M |
| Other current assets | - | -0.02M | -0.01M | - |
| Deferred long term liab | - | - | - | - |
| Non current assets other | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Change in Cash | 1326.23M | 1584.89M | -60.56M | 3081.36M |
| Operating Cash | 4183.36M | 1401.51M | 3059.85M | 3329.13M |
| Free Cash Flow | 1036.67M | -1570.34M | 1114.39M | 1721.82M |
Peer Comparison
Sector: Healthcare Industry: Biotechnology
| Company | Change | Price | Market Cap (M) | P/E Ratio |
|---|---|---|---|---|
| ANTHEM Anthem Biosciences Ltd |
-0.65 -0.11% | 606.75 | 416096.85 | 91.92 |
| BIOCON Biocon Limited |
-3.90 -1.05% | 368.40 | 569444.73 | 94.72 |
| ONESOURCE ONESOURCE SPECIALTY PHARMA LTD |
41.20 3.50% | 1218.80 | 203986.14 | 501.41 |
| CONCORDBIO Concord Biotech Limited |
19.10 1.64% | 1183.20 | 140309.66 | 43.31 |
| BLUEJET Blue Jet Healthcare Limited |
-8.30 -1.97% | 413.00 | 89232.91 | 25.36 |
Profile
Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial manufacturing of RNA-based therapies, antibody-drug conjugates, peptides and oligonucleotides, lipids, biologics and biotherapeutics, fermentation, biosynthesis and biotransformation, and flow chemistry. It also manufactures and sells complex specialized fermentation-based active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2; microbial and mammalian biosimilars; probiotics, such as bacillus species, lactobacillus species, bifidobacterium species, streptococcus species and saccharomyces boulardii; enzymes; peptides, including semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide; nutritional actives, vitamin analogues, and APIs. The company was incorporated in 2006 and is based in Bengaluru, India.
Anthem Biosciences Ltd
No. 49, F1 & F2, Canara Bank Road, Bengaluru, India, 560099
- 91 80 6672 4000
- https://anthembio.com
- Employees : N/A
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Ajay Bhardwaj B.Tech., M.S | Founder, Chairman, MD & CEO | 1960 |
| Mr. K. Ravindra Chandrappa | Co-Founder, COO & Executive Director | 1966 |
| Mr. Mohammed Gawir Baig | Chief Financial Officer | NA |
| Dr. Ganesh Sambasivam | Chief Scientific Officer & Executive Director | 1965 |
| Ms. Divya Prasad | Company Secretary & Compliance Officer | NA |
| Mr. K. Ramakrishnan | General Counsel | NA |
| Mr. Satish Sharma | Vice President of Sales | NA |
| Mr. Rupesh N. Kinekar | Vice President of Marketing | NA |
| Mr. Malay Jiban Barua B.Sc. (Tech), M.Sc.(Tech) | VP & Head of Operations of Specialty Ingredients | 1968 |
| Mr. Ishaan Bhardwaj | Vice President | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.